Published in J Virol on November 01, 1997
Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress. J Virol (2005) 1.69
The capsid of infectious bursal disease virus contains several small peptides arising from the maturation process of pVP2. J Virol (2002) 1.32
C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly. J Virol (2001) 1.22
The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids. J Virol (2002) 1.16
The last C-terminal residue of VP3, glutamic acid 257, controls capsid assembly of infectious bursal disease virus. J Virol (2004) 0.89
Formation of virus-like particles when the polyprotein gene (segment A) of infectious bursal disease virus is expressed in insect cells. Can J Vet Res (1999) 0.86
Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication. J Virol (2010) 0.85
Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PLoS One (2012) 0.83
Early, active, and specific localization of herpes simplex virus type 1 gM to nuclear membranes. J Virol (2009) 0.81
Cyclophilin A Interacts with Viral VP4 and Inhibits the Replication of Infectious Bursal Disease Virus. Biomed Res Int (2015) 0.77
Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein. PLoS One (2015) 0.77
Crystal structures of yellowtail ascites virus VP4 protease: trapping an internal cleavage site trans acyl-enzyme complex in a native Ser/Lys dyad active site. J Biol Chem (2013) 0.77
Non-Lytic Egression of Infectious Bursal Disease Virus (IBDV) Particles from Infected Cells. PLoS One (2017) 0.75
The C-terminal amyloidogenic peptide contributes to self-assembly of Avibirnavirus viral protease. Sci Rep (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Nucleocytoplasmic transport. Science (1996) 8.76
Rotaviruses: a review. Curr Top Microbiol Immunol (1983) 5.24
Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res (1986) 1.96
Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J Virol (1997) 1.78
Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology (1987) 1.68
Characterization of the tubules associated with the replication of three different orbiviruses. Virology (1979) 1.65
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Biochemistry and immunology of infectious bursal disease virus. J Gen Virol (1988) 1.56
Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol (1995) 1.45
Structural and growth characteristics of infectious bursal disease virus. J Virol (1976) 1.37
Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proc Natl Acad Sci U S A (1996) 1.33
Structure of infectious bursal disease virus. J Virol (1974) 1.27
VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol (1997) 1.24
Ultrastructural distribution of the major capsid proteins within bluetongue virus and infected cells. J Gen Virol (1988) 1.18
Demonstration of enzyme activities required for cap structure formation in infectious bursal disease virus, a member of the birnavirus group. J Gen Virol (1990) 1.11
Infectious bursal disease agent: morphology by negative stain electron microscopy. Arch Virol (1975) 1.09
Properties of RNA polymerase activity associated with infectious bursal disease virus and characterization of its reaction products. Virus Res (1987) 1.09
Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide. J Virol (1988) 1.08
Capsid symmetry of viruses of the proposed Birnavirus group. Arch Virol (1985) 1.08
Tubular structures associated with acute nonbacterial gastroenteritis in young children. Infect Immun (1977) 0.93
Electron-microscope studies on the pathogenesis of infectious bursal disease after intrabursal application of the causal virus. Avian Dis (1976) 0.93
Fine-structure studies of the avian infectious bursal agent. I. In vivo viral morphogenesis. Avian Dis (1973) 0.91
Localization of the nonstructural protein NS1 in bluetongue virus-infected cells and its presence in virus particles. Virology (1988) 0.90
Formation, characterization and interfering capacity of a small plaque mutant and of incomplete virus particles of infectious bursal disease virus. Virus Res (1986) 0.90
Three different forms of tubular structures associated with the replication of bovine rotavirus in a tissue culture system. Brief report. Arch Virol (1987) 0.79
Synthesis of the virus-specified tubules of epizootic haemorrhagic disease virus using a baculovirus expression system. Virus Res (1991) 0.79
Electron microscopy of bursa of Fabricius of chicks infected with a field strain of infectious bursal disease virus. Acta Vet Scand (1988) 0.78
Morphogenesis and fine structure of eel virus (Berlin), a member of the proposed Birnavirus group. Arch Virol (1984) 0.78
Immuno-electron microscopic study on the antigenicity of tubular structures associated with human rotavirus. Infect Immun (1981) 0.77
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01
Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis (1996) 3.29
Ultrastructural analysis of the replication cycle of pseudorabies virus in cell culture: a reassessment. J Virol (1997) 3.29
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol (1991) 3.00
Egress of alphaherpesviruses: comparative ultrastructural study. J Virol (2001) 2.92
Primary envelopment of pseudorabies virus at the nuclear membrane requires the UL34 gene product. J Virol (2000) 2.91
Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol (1985) 2.70
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63
Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus. J Virol (1999) 2.52
Cognitive processes mediating behavioral change. J Pers Soc Psychol (1977) 2.46
Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J Virol (1988) 2.24
Effect of the pseudorabies virus US3 protein on nuclear membrane localization of the UL34 protein and virus egress from the nucleus. J Gen Virol (2001) 2.23
Antibody to hepatitis C virus in German blood donors. Lancet (1989) 2.21
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex. J Virol (1985) 2.14
Role of pseudorabies virus glycoprotein gI in virus release from infected cells. J Virol (1987) 2.11
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter (1996) 2.10
Glycoprotein gIII of pseudorabies virus is multifunctional. J Virol (1988) 2.05
Pseudorabies virus UL37 gene product is involved in secondary envelopment. J Virol (2001) 2.01
Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb Drug Resist (2004) 1.97
Pseudorabies virus glycoprotein M inhibits membrane fusion. J Virol (2000) 1.94
Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science (1995) 1.93
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol (2003) 1.86
Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex. J Virol (1998) 1.79
Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J Virol (1985) 1.78
Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. J Gen Virol (1994) 1.73
Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation. Virology (1996) 1.72
Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology (1993) 1.72
Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein. J Virol (1999) 1.70
Pathology of natural infections by H5N1 highly pathogenic avian influenza virus in mute (Cygnus olor) and whooper (Cygnus cygnus) swans. Vet Pathol (2007) 1.70
Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J Virol (2000) 1.67
Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J Virol (1996) 1.66
Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J Virol (1991) 1.64
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother (1994) 1.62
Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H. J Virol (1997) 1.59
A non-canonical lon proteinase lacking the ATPase domain employs the ser-Lys catalytic dyad to exercise broad control over the life cycle of a double-stranded RNA virus. EMBO J (2000) 1.58
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol (2003) 1.53
The UL20 gene product of pseudorabies virus functions in virus egress. J Virol (1997) 1.52
Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol (1999) 1.50
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors. Ann Oncol (2012) 1.49
Pseudorabies virus glycoprotein K requires the UL20 gene product for processing. J Virol (2000) 1.49
Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component. J Virol (1996) 1.48
Comparison of glycemic response and insulin requirements after mixed meals of equal carbohydrate content in healthy, type-1, and type-2 diabetic man. Klin Wochenschr (1989) 1.46
Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol (1995) 1.45
Interactive Volume Exploration of Petascale Microscopy Data Streams Using a Visualization-Driven Virtual Memory Approach. IEEE Trans Vis Comput Graph (2012) 1.45
Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry. J Virol (1998) 1.44
Sequence and expression of the glycoprotein gH gene of pseudorabies virus. Virology (1991) 1.43
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.43
Role of essential glycoproteins gII and gp50 in transneuronal transfer of pseudorabies virus from the hypoglossal nerves of mice. J Virol (1993) 1.41
Stable rescue of a glycoprotein gII deletion mutant of pseudorabies virus by glycoprotein gI of bovine herpesvirus 1. J Virol (1992) 1.41
Biocompatibility of alginates for grafting: impact of alginate molecular weight. Artif Cells Blood Substit Immobil Biotechnol (2003) 1.40
Abnormal pentagastrin response in a patient with pseudohypoparathyroidism. Exp Clin Endocrinol Diabetes (2002) 1.40
Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening. Transfusion (1994) 1.40
Glycoprotein gH of pseudorabies virus is essential for penetration and propagation in cell culture and in the nervous system of mice. J Gen Virol (1996) 1.39
Green fluorescent protein expressed by recombinant pseudorabies virus as an in vivo marker for viral replication. J Virol Methods (1997) 1.38
[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]. Dtsch Med Wochenschr (2000) 1.38
[Therapy of diabetes in adults using Glibornurid. Results and clinical studies]. Dtsch Med Wochenschr (1973) 1.38
Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha. Virology (1995) 1.38
Molecular typing of Helicobacter pylori isolates from a multicenter U.S. clinical trial by ureC restriction fragment length polymorphism. J Clin Microbiol (1997) 1.37
Glycoprotein IV of bovine herpesvirus 1-expressing cell line complements and rescues a conditionally lethal viral mutant. J Virol (1992) 1.37
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007. Transbound Emerg Dis (2009) 1.37
Identification and characterization of a novel structural glycoprotein in pseudorabies virus, gL. J Virol (1994) 1.36
The UL49.5 gene of pseudorabies virus codes for an O-glycosylated structural protein of the viral envelope. J Virol (1996) 1.36
A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus. J Virol (2001) 1.35
Pseudorabies virus in wild swine: a global perspective. Arch Virol (2011) 1.33
Location of the structural gene of pseudorabies virus glycoprotein complex gII. Virology (1986) 1.32
Synaptic and neurotransmitter activation of cardiac vagal neurons in the nucleus ambiguus. Ann N Y Acad Sci (2001) 1.32
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplant (2003) 1.31
Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. Virology (1994) 1.30
Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Microb Drug Resist (1999) 1.30
Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther (2012) 1.29
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer (2001) 1.29
Rapid molecular subtyping by reverse transcription polymerase chain reaction of the neuraminidase gene of avian influenza A viruses. Vet Microbiol (2008) 1.29
Pseudorabies virus and equine herpesvirus 1 share a nonessential gene which is absent in other herpesviruses and located adjacent to a highly conserved gene cluster. J Virol (1995) 1.28
Herpesvirus (pseudorabies virus) latency in swine: occurrence and physical state of viral DNA in neural tissues. Virology (1986) 1.26
Identification and characterization of pseudorabies virus glycoprotein H. J Virol (1992) 1.26
Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens. J Gen Virol (2002) 1.26
Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis (1995) 1.25
Adaptability in herpesviruses: glycoprotein D-independent infectivity of pseudorabies virus. J Virol (1997) 1.24
VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol (1997) 1.24
Invasion and spread of single glycoprotein deleted mutants of Aujeszky's disease virus (ADV) in the trigeminal nervous pathway of pigs after intranasal inoculation. Vet Microbiol (1994) 1.22
Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int (2006) 1.21
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst (2000) 1.21
Distribution of lesions and antigen of highly pathogenic avian influenza virus A/Swan/Germany/R65/06 (H5N1) in domestic cats after presumptive infection by wild birds. Vet Pathol (2007) 1.21
Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation. Virology (1997) 1.20
Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine. J Virol (1993) 1.20
Suprachiasmatic nucleus: a central autonomic clock. Nat Neurosci (1999) 1.20
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol (1999) 1.17
Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components. J Virol (1989) 1.17
Cell surface proteoglycans are not essential for infection by pseudorabies virus. J Virol (1995) 1.17
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis. J Clin Oncol (1999) 1.16
Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study. Eur J Clin Invest (1986) 1.16